What is Avalo Therapeutics's compensation and benefits?

Avalo Therapeutics (AVTX) reported compensation and benefits of $1.75M in Q1 2026.

How has Avalo Therapeutics's compensation and benefits changed year-over-year?

Avalo Therapeutics's compensation and benefits decreased by 1.0% year-over-year, from $1.77M to $1.75M.

What is the long-term trend for Avalo Therapeutics's compensation and benefits?

Over 5 years (2020 to 2025), Avalo Therapeutics's compensation and benefits has grown at a 5.8% compound annual growth rate (CAGR), from $3.12M to $4.13M.

Avalo Therapeutics AVTX Compensation and benefits

Compensation and benefits at other companies

Eli LillyLLY

——

AbCellera Biologics Inc.ABCL

——

Absci CorporationABSI

——

Arcus BiosciencesRCUS

——

Aurinia PharmaceuticalsAUPH

——

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's compensation and benefits?: Avalo Therapeutics (AVTX) reported compensation and benefits of $1.75M in Q1 2026.
How has Avalo Therapeutics's compensation and benefits changed year-over-year?: Avalo Therapeutics's compensation and benefits decreased by 1.0% year-over-year, from $1.77M to $1.75M.
What is the long-term trend for Avalo Therapeutics's compensation and benefits?: Over 5 years (2020 to 2025), Avalo Therapeutics's compensation and benefits has grown at a 5.8% compound annual growth rate (CAGR), from $3.12M to $4.13M.